跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle - TGA Drug Approval Details
Approvals
/
TGA
/
XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle
Approved
STANDARD
XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a78e14364238d43d
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
a78e14364238d43d
Product Name
XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle
Artg Id
168143
Artg Name
XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2010-01-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a78e14364238d43d
Type
Standard
Back to TGA Approvals
